Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MicroOptx
AddedFeb 15, 2024
UpdatedJun 18, 2026
MicroOptx

MicroOptx

Series C

MicroOptx: A medical device company innovating platform technology for eye health solutions.

HQ
Maple Grove, MN, US
Founded
2014
Overview
Compare
Fundraising
Employees

MicroOptx is a medical device company focused on developing innovative platform technology to improve eye health. Their primary product aims to shunt aqueous humor from the anterior chamber to the surface of the eye, addressing conditions like glaucoma. The company is dedicated to advancing eye care through cutting-edge solutions.

MicroOptx has made significant strides in the medical device industry, earning recognition for its pioneering technology. Their impact on eye health has been notable, contributing to better management of ocular conditions. The company continues to push the boundaries of medical innovation in ophthalmology.

MicroOptx - Similar Companies

TherOptix logo

TherOptix

Iscience Surgical logo

Iscience Surgical

Glaukos logo

Glaukos

glaukos.com

Optovue logo

Optovue

Opticent Health logo

Opticent Health

opticenthealth.com

Micro Medical Solutions logo

Micro Medical Solutions

Nanophthalmics logo

Nanophthalmics

Sight Sciences logo

Sight Sciences

sightsciences.com

Optobionics logo

Optobionics

optobionics.com

OcuMedic logo

OcuMedic

EyeIC logo

EyeIC

Opticyte logo

Opticyte

opticyte.com

OcuSciences logo

OcuSciences

ocusciences.com

Intelon Optics logo

Intelon Optics

Myra Vision logo

Myra Vision

myravision.com

MicroOptx - Quick Facts

Who are MicroOptx's competitors?

Companies similar to MicroOptx include TherOptix, Iscience Surgical, Glaukos and Optovue.

When was MicroOptx founded?

MicroOptx was founded in 2014.

Where is MicroOptx's headquarters located?

MicroOptx's headquarters is located in Maple Grove, MN, US.

When was MicroOptx's last funding round?

MicroOptx's most recent funding round was for $3M (USD) in August 2019.

How much has MicroOptx raised to-date?

As of Aug 5, 2019, MicroOptx has raised a total of $19.2M (USD).

How many employees does MicroOptx have?

MicroOptx has 15 employees as of Feb 5, 2024.

MicroOptx - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
  • HealthTech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Hardware
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified